Clinical Trial Update: Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis [Phase 3]

View source ↗

Summary

This is a Phase 3 open-label trial of GW685698X in pediatric patients with perennial allergic rhinitis. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis

Drugs mentioned

• GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2013-08-12